139 related articles for article (PubMed ID: 11404347)
1. The use of intraallelic variability for testing neutrality and estimating population growth rate.
Slatkin M; Bertorelle G
Genetics; 2001 Jun; 158(2):865-74. PubMed ID: 11404347
[TBL] [Abstract][Full Text] [Related]
2. Estimating the age of alleles by use of intraallelic variability.
Slatkin M; Rannala B
Am J Hum Genet; 1997 Feb; 60(2):447-58. PubMed ID: 9012419
[TBL] [Abstract][Full Text] [Related]
3. The case for selection at CCR5-Delta32.
Sabeti PC; Walsh E; Schaffner SF; Varilly P; Fry B; Hutcheson HB; Cullen M; Mikkelsen TS; Roy J; Patterson N; Cooper R; Reich D; Altshuler D; O'Brien S; Lander ES
PLoS Biol; 2005 Nov; 3(11):e378. PubMed ID: 16248677
[TBL] [Abstract][Full Text] [Related]
4. The geographic spread of the CCR5 Delta32 HIV-resistance allele.
Novembre J; Galvani AP; Slatkin M
PLoS Biol; 2005 Nov; 3(11):e339. PubMed ID: 16216086
[TBL] [Abstract][Full Text] [Related]
5. Simulating genealogies of selected alleles in a population of variable size.
Slatkin M
Genet Res; 2001 Aug; 78(1):49-57. PubMed ID: 11556137
[TBL] [Abstract][Full Text] [Related]
6. Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls.
Weiss FU; Simon P; Bogdanova N; Mayerle J; Dworniczak B; Horst J; Lerch MM
Gut; 2005 Oct; 54(10):1456-60. PubMed ID: 15987793
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci.
Cao K; Moormann AM; Lyke KE; Masaberg C; Sumba OP; Doumbo OK; Koech D; Lancaster A; Nelson M; Meyer D; Single R; Hartzman RJ; Plowe CV; Kazura J; Mann DL; Sztein MB; Thomson G; Fernández-Viña MA
Tissue Antigens; 2004 Apr; 63(4):293-325. PubMed ID: 15009803
[TBL] [Abstract][Full Text] [Related]
8. Using the distribution of the CCR5-Δ32 allele in third-generation Maltese citizens to disprove the Black Death hypothesis.
Baron B; Schembri-Wismayer P
Int J Immunogenet; 2011 Apr; 38(2):139-43. PubMed ID: 21156032
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the CCR5 Delta32 mutation based on haplotype variation in Jewish and Northern European population samples.
Klitz W; Brautbar C; Schito AM; Barcellos LF; Oksenberg JR
Hum Immunol; 2001 May; 62(5):530-8. PubMed ID: 11334678
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis gene variability in two southern Brazilian Amerindian populations: analysis of the deltaF508 mutation and the KM19 and XV2C haplotypes.
Raskin S; Petzl-Erler ML; Phillips JA; Pereira-Ferrari L; Probst CM; Faucz FR; Sotomaior V; Salzano FM; Culpi L
Hum Biol; 2007 Feb; 79(1):79-91. PubMed ID: 17985657
[TBL] [Abstract][Full Text] [Related]
11. Haplotype distribution of and linkage disequilibrium between four polymorphic markers near the CFTR locus in Brazilian cystic fibrosis patients.
Cabello GM; Cabello PH; Lopez-Camelo JS; Llerena JC; Fernandes O
Hum Biol; 2005 Dec; 77(6):853-65. PubMed ID: 16715841
[TBL] [Abstract][Full Text] [Related]
12. Study of mutant and polyvariant mutant CFTR genes in patients with congenital absence of the vas deferens.
Ravnik-Glavac M; Dean M; Glavac D
Pflugers Arch; 2000; 439(3 Suppl):R53-5. PubMed ID: 10653141
[TBL] [Abstract][Full Text] [Related]
13. A haplotype framework for cystic fibrosis mutations in Iran.
Elahi E; Khodadad A; Kupershmidt I; Ghasemi F; Alinasab B; Naghizadeh R; Eason RG; Amini M; Esmaili M; Esmaeili Dooki MR; Sanati MH; Davis RW; Ronaghi M; Thorstenson YR
J Mol Diagn; 2006 Feb; 8(1):119-27. PubMed ID: 16436643
[TBL] [Abstract][Full Text] [Related]
14. Allele age and a test for selection on rare alleles.
Slatkin M
Philos Trans R Soc Lond B Biol Sci; 2000 Nov; 355(1403):1663-8. PubMed ID: 11127913
[TBL] [Abstract][Full Text] [Related]
15. XV-2c and KM.19 haplotype analysis in Chilean patients with cystic fibrosis and unknown CFTR gene mutations.
Repetto GM; Puga AR; Delgado I
Biol Res; 2007; 40(2):223-9. PubMed ID: 18064359
[TBL] [Abstract][Full Text] [Related]
16. Statistical estimation and pedigree analysis of CCR2-CCR5 haplotypes.
Clark VJ; Metheny N; Dean M; Peterson RJ
Hum Genet; 2001 Jun; 108(6):484-93. PubMed ID: 11499673
[TBL] [Abstract][Full Text] [Related]
17. Joint Bayesian estimation of mutation location and age using linkage disequilibrium.
Rannala B; Reeve JP
Pac Symp Biocomput; 2003; ():526-34. PubMed ID: 12603055
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.
Malats N; Casals T; Porta M; Guarner L; Estivill X; Real FX
Gut; 2001 Jan; 48(1):70-4. PubMed ID: 11115825
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of 23 exons of the CFTR gene in Brazilian patients leads to the finding of rare cystic fibrosis mutations.
Cabello GM; Cabello PH; Otsuki K; Gombarovits ME; Llerena JC; Fernandes O
Hum Biol; 2005 Feb; 77(1):125-35. PubMed ID: 16114821
[TBL] [Abstract][Full Text] [Related]
20. Estimating allele age.
Slatkin M; Rannala B
Annu Rev Genomics Hum Genet; 2000; 1():225-49. PubMed ID: 11701630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
